EXHIBIT 10.1

     ENCORIUM GROUP, INC. 2002 EQUITY INCENTIVE PLAN

AMENDED AND RESTATED NON-QUALIFIED STOCK OPTION AWARD AGREEMENT

     WHEREAS, on September 8, 2008 (the “Date of Grant”) the Encorium Group,
Inc. (the “Company”) granted to Dr. David Ginsberg (the “Optionee”) an option to
purchase a total of 250,000 shares of Common Stock of the Company with an
exercise price of $1.70 per share (the “Original Option”), which was the Fair
Market Value on the Date of Grant;

     WHEREAS the Original Option is evidenced by that certain Non-Qualified
Stock Option Award Agreement dated September 8, 2008;

     WHEREAS, the Original Option was granted to the Optionee in order to
provide a performance incentive and to more closely align the interests of the
Optionee with those of the Company’s stockholders in maximizing stockholder
value;

     WHEREAS, as a result of the decline in the Company's stock price
immediately after the date of grant of the Original Option, the Compensation
Committee believes that such Original Option is not achieving the purposes for
which it was intended and that it is in the best interest of the Company and its
stockholders to reprice the Original Option in order to properly incentivize the
Optionee;

     WHEREAS to assure the Company that it will have the continued dedication of
the Optionee and the availability of his advice and counsel notwithstanding the
possibility, threat, or occurrence of a Change in Control (as hereinafter
defined) of the Company the Board of Directors believes that it is in the best
interest of the Company and its stockholders to provide for an acceleration of
the Original Option upon a Change of Control.

     WHEREAS, on November 4, 2008 (the “Repricing Date”), the Compensation
Committee of the board of directors of the Company acted to reprice the Original
Option to have an exercise price equal to the closing price of the Company's
common stock on November 4, 2008, which was $ .36 per share and to provide that
the Original Option shall vest immediately upon a “Change of Control” of the
Company; and

     WHEREAS, in order to effect the amendments set forth above, the Company
hereby amends and restates the Original Option Agreement to read as follows:

     The Company hereby grants to the Optionee an option to purchase a total of
250,000 shares of Common Stock of the Company (the “Option”), at the price and
on the terms set forth herein, and in all respects subject to the terms,
definitions and provisions of the Encorium Group, Inc.(formerly, Covalent Group,
Inc.) 2002 Equity Incentive Plan (the “Plan”) applicable to non-qualified stock
options, which terms and provisions are hereby incorporated by reference herein.

GV: #223938 v3 (4SS$03!.DOC)

--------------------------------------------------------------------------------

Unless otherwise provided for herein or unless the context herein otherwise
requires, the terms defined in the Plan shall have the same meanings when used
herein.

    1.    Nature of the Option. This Option is not intended to be an incentive 
stock option.                2.    Term of Option. This Option may not be
exercised later than the date 

that is ten (10) years after the Date of Grant, subject to earlier termination,
as provided in the Plan or Section 6 hereof.

     3. Option Exercise Price. The cost to the Optionee to purchase, pursuant to
this Award Agreement, one Share is $ .36, which is the Fair Market Value on the
Repricing Date.

     4. Exercise of Option. This Option shall be exercisable during its term
only in accordance with the terms and provisions of the Plan and this Award
Agreement as follows:

(a)      Right to Exercise.   (i)      The Option shall become exercisable with
respect to 83,333 Shares if the  

Optionee remains continuously employed by the Company through the first (1st)
anniversary of the Date of Grant.

     (ii) The Option shall become exercisable with respect to 83,333 Shares if
the Optionee remains continuously employed by the Company through the second
(2nd) anniversary of the Date of Grant.

     (iii) The Option shall become exercisable with respect to 83,334 Shares if
the Optionee remains continuously employed by the Company through the third
(3rd) anniversary of the Date of Grant.

     (b) Accelerated Vesting. The Option shall become exercisable immediately
upon a Change of Control of the Company. “Change in Control” of the Company
under this Agreement shall be deemed to have occurred as of the first day that
any one or more of the following conditions shall have been satisfied:

     (i) When a “person”, as defined in Sections 3(a)(9) and 13(d)(3) of the
Exchange Act, becomes the beneficial owner, directly or indirectly, of
securities of the Company representing (A) more than twenty percent (20%) of the
combined voting power of the Company’s then outstanding securities, unless such
person is subject to contractual restrictions that would preclude him from
voting such shares in a manner to influence or control the management of the
Company’s business, provided that in the event such contractual restrictions are
removed, a Change of Control will be deemed to have occurred on the effective
date of such removal, or (B) one hundred percent (100%) of the combined voting
power of the Company’s then outstanding securities regardless of any contractual
restrictions. For purposes of this provision, “person” shall not include the
Company, any subsidiary of the Company, any employee benefit plan or employee
stock plan of the Company, or any person holding the Company’s Common Stock by
for or pursuant to the terms of such a plan; and “voting power”

-2-

GV: #223938 v3 (4SS$03!.DOC)

--------------------------------------------------------------------------------

shall mean the power under ordinary circumstances (and not merely upon the
happening of a contingency) to vote in the election of directors.

     (ii) When, as a result of a vote of stockholders for which proxies are
solicited by or on behalf of any person other than the Company in accordance
with the SEC rules issued under Section 14 of the Exchange Act, or which is
exempt from the SEC proxy rules by reason of Rule 14a-2 under the Exchange Act,
or as a result of an action by written consent of stockholders without a
meeting, the “incumbent directors” cease to constitute at least a majority of
the authorized number of members of the Board. For purposes of this provision,
“incumbent directors” shall mean the persons who were members of the Board on
the date hereof (including Executive’s nominees), and the persons who were
elected or nominated as their successors or pursuant to increases in the size of
the Board by a vote of at least an absolute majority (and not just the majority
of a quorum) of the Board members who were then Board members (or successors or
additional members so elected or nominated).

     (iii) When the stockholders of the Company approve a merger, consolidation,
or reorganization, whether or not the Company is the surviving entity in such
transaction, other than a merger, consolidation, or reorganization that would
result in the voting securities of the Company outstanding immediately prior
thereto continuing to represent (either by remaining outstanding or by being
converted into voting securities of the surviving entity) at least seventy
percent (70%) of the combined voting power of the voting securities, held in
relatively the same proportion, of the Company (or such surviving entity)
outstanding immediately after the merger, consolidation, or reorganization.

     (iv) When the stockholders of the Company approve (A) the sale or other
disposition of all or substantially all of the assets the company or (B) a
complete liquidation or dissolution of the Company.

     (v) When the Board adopts a resolution to the effect that any person has
acquired effective control of the business and affairs of the Company.

     (c) Method of Exercise. The Optionee may exercise this Option by providing
written notice stating the election to exercise this Option. Such written notice
must be signed by the Optionee and must be delivered in person or by certified
mail to the Chief Financial Officer of the Company or such other person as may
be designated by the Company. The written notice must be accompanied by payment
of the option exercise price in the manner described in Section 4(d), by an
executed exercise form provided by the administrator and by any other agreements
required by the Board or its Committee and/or the terms of the Plan, which other
agreements may restrict the sale or other transfer of the Shares and may include
certain additional representations and agreements as to the Optionee’s
investment intent with respect to the Shares. This Option will be deemed to be
exercised only upon the receipt by the Company of such written notice, payment
of the option exercise price, and duly executed copies of the exercise form and
any other agreements required by the Board or its Committee, the terms of the
Plan and/or this Award Agreement. The Optionee will have no right to vote or
receive dividends and will have no other rights as a stockholder with respect to
such Shares notwithstanding the exercise of this Option, until the issuance (as
evidenced by the appropriate entry on the books of the Company or of a duly
authorized transfer agent of the Company) of the stock certificate(s)

-3-

GV: #223938 v3 (4SS$03!.DOC)

--------------------------------------------------------------------------------

evidencing Shares that are being issued upon exercise of this Option. The
certificate(s) for the Shares will be registered in the name of the Optionee and
will contain any legend as may be required under the Plan, this Award Agreement,
and/or applicable law.

     (d) Method of Payment. The method of payment of the option exercise price
will be determined by the Board or its Committee and may consist entirely of
cash, certified check, or such other consideration or method of payment as may
be authorized under the Plan.

     (e) Partial Exercise. This Option may be exercised in whole or in part;
provided, however, that any exercise may apply only with respect to a whole
number of Shares.

     (f) Restrictions on Exercise. This Option may not be exercised if the
issuance of these Shares upon such exercise would constitute a violation of any
applicable federal or state securities laws or other laws or regulations. In
addition, as a further condition to the exercise of this Option, the Company may
require the Optionee to make any representation or warranty to the Company as
may be required by or advisable under any applicable law or regulation.

5. Investment Representations. Unless the Shares have been registered under the

Securities Act of 1933, in connection with the acquisition of this Option, the
Optionee represents and warrants to the Company as follows:

     (a) The Optionee is acquiring this Option, and upon exercise of this
Option, the Optionee will be acquiring the Shares for investment for his or her
own account, not as a nominee or agent, and not with a view to or for resale in
connection with any distribution thereof.

     (b) The Optionee has a preexisting business or personal relationship with
the Company or one of its directors, officers or controlling persons and by
reason of his or her business or financial experience, has, and could be
reasonably assumed to have, the capacity to protect his interests in connection
with the acquisition of this Option and the Shares.

6.      Termination of Relationship with the Company.     (a) Generally. If the
Optionee’s employment by the Company is terminated  

voluntarily for any reason other than death, Disability or termination for
Cause, the Option (to the extent exercisable at the time of such termination)
may be exercised at any time within three (3) months after the date of such
termination. To the extent that the Option is not exercisable at the time of
such termination, or to the extent the Option is not exercised within the time
specified herein, the Option shall terminate.

     (b) Disability. If the Optionee’s employment by the Company terminates due
to Disability, the Option (to the extent exercisable at the time of such
termination) may be exercised by the Optionee or his legal guardian or
representative at any time within twelve (12) months after such termination. To
the extent that the Option is not exercisable on the date of termination, or to
the extent the Option is not exercised within the time specified herein, the
Option shall terminate.

     (c) Death. If the Optionee’s employment by the Company terminates due to
his death, the Option (to the extent exercisable at the time of such death) will
remain exercisable for twelve (12) months after the date of death by the
Optionee’s estate or by a person who acquired the right to exercise the Option
by bequest or inheritance. To the extent that the Option is not exercisable on
the date of death, or to the extent the Option is not exercised within the time
specified herein, the Option shall terminate.

-4-

GV: #223938 v3 (4SS$03!.DOC)

--------------------------------------------------------------------------------

     (d) Termination for Cause. If the Optionee’s employment is terminated for
Cause, the Option will then terminate immediately and automatically, and the
Optionee shall have no further rights therein.

Notwithstanding any other provision of this Section 6, the Option shall not be
exercisable after the expiration of the term set forth in Section 2 hereof.

     7. Non-Transferability of Option. This Option may not be sold, pledged,
assigned, hypothecated, gifted, transferred or disposed of in any manner either
voluntarily or involuntarily by operation of law, other than by will or by the
laws of descent or distribution. During the Optionee’s lifetime, this Option is
exercisable only by the Optionee (or by such Optionee’s legal guardian or
representative as provided in Section 6). Subject to the foregoing and the terms
of the Plan, the terms of this Option will be binding upon the executors,
administrators and heirs of the Optionee, meaning for purposes of this Award
Agreement, both testamentary heirs and heirs by intestacy.

8. No Continuation of Employment or Engagement. Neither the Plan nor this

Option shall confer upon any Optionee any right to continue in the service of
the Company or any of its Subsidiaries or limit, in any respect, the right of
the Company to discharge the Optionee at any time, with or without cause and
with or without notice.

     9. Market Stand-Off. The Optionee agrees that, in connection with any
public offering by the Company of its equity securities pursuant to a
registration statement filed under the Securities Act, not to sell, make any
short sale of, loan, hypothecate, pledge, grant any option for the purchase of
or otherwise dispose of any Shares without the prior written consent of the
Company or its underwriters, for such period of time from the effective date of
such registration as may be requested by the Company or such underwriters.

     10. Withholding. The Company reserves the right to withhold, in accordance
with any applicable laws, from any consideration payable or property
transferable to Optionee any taxes required to be withheld by federal, state or
local law as a result of the grant or exercise of this Option or the sale or
other disposition of the Shares. If the amount of any consideration payable to
the Optionee is insufficient to pay such taxes or if no consideration is payable
to the Optionee, upon the request of the Company, the Optionee (or such other
person entitled to exercise this Option pursuant to Section 6 hereof) will pay
to the Company an amount sufficient for the Company to satisfy any federal,
state or local tax withholding requirements applicable to the grant or exercise
of this Option or the sale or other disposition of the Shares issued upon the
exercise of this Option.

     11. The Plan. The Optionee has received a copy of the Plan (a copy of which
is attached hereto), has read the Plan and is familiar with its terms, and
hereby accepts the Option subject to all of the terms and provisions of the
Plan, as amended from time to time. Pursuant to the Plan, the Board or its
Committee is authorized to interpret the Plan and to adopt rules and regulations
not inconsistent with the Plan as it deems appropriate. The Optionee hereby
agrees to accept as binding, conclusive and final all decisions or
interpretations of the Board or its Committee upon any questions arising under
the Plan.

     12. Governing Law. This Award Agreement will be construed in accordance
with the laws of the State of Delaware, without regard to the application of the
principles of conflicts of laws.

     13. Amendment. Subject to the provisions of the Plan, this Award Agreement
may only be amended by a writing signed by each of the parties hereto.

-5-

GV: #223938 v3 (4SS$03!.DOC)

--------------------------------------------------------------------------------

     14. Entire Agreement. This Award Agreement, together with the Plan and the
other exhibits attached thereto or hereto, represents the entire agreement
between the parties hereto relating to the subject matter hereof, and merges and
supersedes all prior and contemporaneous discussions, agreements and
understandings of every nature relating to the award of Options to Optionee by
the Company. This Award Agreement may not be changed or modified, except by an
agreement in writing signed by each of the parties hereto.

     IN WITNESS WHEREOF, this Award Agreement has been executed by the parties
on the 4th day of November, 2008.

ENCORIUM GROUP, INC.          By:    /s/ Kai Lindevall     

--------------------------------------------------------------------------------

Name:    Kai Lindevall      Title:    Chairman of the Board and President    of 
    European and Asian Operations          OPTIONEE          ___/s/ David
Ginsberg________      Signature     

THIS OPTION AND THE SECURITIES WHICH MAY BE PURCHASED UPON EXERCISE OF THIS
OPTION HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
ANY APPLICABLE STATE SECURITIES LAWS. THESE SECURITIES HAVE NOT BEEN ACQUIRED
WITH A VIEW TO DISTRIBUTION OR RESALE, AND MAY NOT BE SOLD, ASSIGNED, EXCHANGED,
MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR DISPOSED OF, BY
GIFT OR OTHERWISE, OR IN ANY WAY ENCUMBERED WITHOUT AN EFFECTIVE REGISTRATION
STATEMENT FOR SUCH SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND
ANY APPLICABLE STATE SECURITIES LAWS, OR A SATISFACTORY OPINION OF COUNSEL
SATISFACTORY TO COVALENT GROUP, INC. THAT REGISTRATION IS NOT REQUIRED UNDER
SUCH ACT AND UNDER APPLICABLE STATE SECURITIES LAWS.

-6-

GV: #223938 v3 (4SS$03!.DOC)

--------------------------------------------------------------------------------